The global Oncology Nuclear Medicine Equipment market size is predicted to grow from US$ 1886 million in 2025 to US$ 3094 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.

In 2025, the global annual production capacity of oncology nuclear medicine equipment reached approximately 1,950 units, while actual production was about 1,543 units. The global average market price was approximately US$1.25 million per unit. Major manufacturers in the industry achieved gross profit margins ranging from 45% to 65%, reflecting strong technological barriers and high regulatory value. Oncology nuclear medicine equipment refers to imaging and therapeutic systems that use radioactive tracers to diagnose, stage, and treat malignant tumors. Typical equipment includes PET, PET/CT, PET/MR scanners, gamma cameras, and radionuclide therapy systems, enabling functional imaging and targeted radiotherapy for cancer management.

Upstream of the oncology nuclear medicine equipment industry includes scintillation crystals, photodetectors, high-voltage power modules, superconducting magnets, precision electronics, and radioisotope components. Midstream manufacturers integrate imaging systems, detectors, software algorithms, and system calibration, with leading players concentrated in the US, Europe, and China. Downstream applications are primarily hospitals, oncology centers, and nuclear medicine departments. End users focus on image resolution, quantitative accuracy, radiation dose control, system reliability, and regulatory compliance.

The oncology nuclear medicine equipment market is driven by the rising global cancer incidence and the shift toward precision diagnostics and targeted therapy. PET-based imaging systems continue to gain adoption due to their superior functional imaging capabilities. Advances in detector technology, AI-assisted image reconstruction, and hybrid imaging systems are improving diagnostic accuracy and workflow efficiency. Emerging markets are becoming key growth drivers as healthcare infrastructure and nuclear medicine capacity expand. Overall, the market demonstrates strong long-term growth potential supported by clinical demand and technological innovation.

Infinity Market Research newest research report, the ?Oncology Nuclear Medicine Equipment Industry Forecast? looks at past sales and reviews total world Oncology Nuclear Medicine Equipment sales in 2025, providing a comprehensive analysis by region and market sector of projected Oncology Nuclear Medicine Equipment sales for 2026 through 2032. With Oncology Nuclear Medicine Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Nuclear Medicine Equipment industry.

This Insight Report provides a comprehensive analysis of the global Oncology Nuclear Medicine Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Nuclear Medicine Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oncology Nuclear Medicine Equipment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Nuclear Medicine Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Nuclear Medicine Equipment.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Nuclear Medicine Equipment market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Fixed
    Mobile
    Segmentation by Clinical Function:
    Diagnostic Nuclear Medicine Equipment
    Therapeutic Nuclear Medicine Equipment
    Integrated Diagnosis & Therapy Equipment

Segmentation by Application:

    Hospital
    Radiation Therapy Center

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Siemens Healthineers
    Elekta
    Accuray
    United Imaging Healthcare
    Suzhou Lintek
    Neusoft Medical
    Shinva Medical
    China Isotope & Radiation Corporation
    Huiheng Medical
    Shenzhen Yitai Medical
    Yingkang Life Science
    Dazhao Group
    Best Theratronics
    Ion Beam Applications
    BEBIG Medical
    Mevion Medical Systems
    Best Cyclotron Systems
    Advanced Cyclotron Systems
    Sumitomo Heavy Industries

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oncology Nuclear Medicine Equipment market?
What factors are driving Oncology Nuclear Medicine Equipment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oncology Nuclear Medicine Equipment market opportunities vary by end market size?
How does Oncology Nuclear Medicine Equipment break out by Type, by Application?